{"id":311904,"date":"2020-01-03T20:16:12","date_gmt":"2020-01-04T04:16:12","guid":{"rendered":"https:\/\/nai500.com\/blog\/2020\/01\/leap-therapeutics-and-beigene-announce-exclusive-option-and-license-agreement\/"},"modified":"2020-01-03T20:16:28","modified_gmt":"2020-01-04T04:16:28","slug":"leap-therapeutics-%e5%92%8c%e4%b8%ad%e5%9b%bd%e4%bc%81%e4%b8%9a%e8%be%be%e6%88%90%e5%85%8d%e7%96%ab%e8%82%bf%e7%98%a4%e8%8d%af%e7%89%a9%e6%8e%88%e6%9d%83%e8%ae%b8%e5%8f%af%e5%8d%8f%e8%ae%ae","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2020\/01\/leap-therapeutics-%e5%92%8c%e4%b8%ad%e5%9b%bd%e4%bc%81%e4%b8%9a%e8%be%be%e6%88%90%e5%85%8d%e7%96%ab%e8%82%bf%e7%98%a4%e8%8d%af%e7%89%a9%e6%8e%88%e6%9d%83%e8%ae%b8%e5%8f%af%e5%8d%8f%e8%ae%ae\/","title":{"rendered":"Leap Therapeutics\u548c\u4e2d\u56fd\u4f01\u4e1a\u8fbe\u6210\u514d\u75ab\u80bf\u7624\u836f\u7269\u6388\u6743\u8bb8\u53ef\u534f\u8bae"},"content":{"rendered":"<p>\u5f00\u53d1\u9776\u5411\u514d\u75ab\u80bf\u7624\u7597\u6cd5\u7684\u751f\u7269\u6280\u672f\u516c\u53f8Leap Therapeutics\uff0cInc.\uff08Nasdaq\uff1aLPTX\uff09\u548c\u4e13\u6ce8\u4e8e\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u521b\u65b0\u5206\u5b50\u7684\u5546\u4e1a\u5316\u751f\u7269\u5236\u836f\u516c\u53f8\u767e\u6d4e\u795e\u5dde\u5ba3\u5e03\uff0c\u5c31Leap Therapeutics\u7684Dickkopf-1\uff08DKK1\uff09\u6297\u4f53DKN-01\u5728\u4e9a\u6d32\uff08\u65e5\u672c\u9664\u5916\uff09\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u65b0\u897f\u5170\u7684\u4e34\u5e8a\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u8fbe\u6210\u4e86\u72ec\u5bb6\u9009\u62e9\u6743\u548c\u8bb8\u53ef\u534f\u8bae\u3002Leap Therapeutics\u5c06\u4fdd\u7559\u5728\u4e16\u754c\u5176\u4ed6\u5730\u533a\u5f00\u53d1\u3001\u751f\u4ea7\u548c\u5546\u4e1a\u5316DKN-01\u7684\u72ec\u5bb6\u6743\u5229\u3002\u6b64\u5916\uff0cLeap Therapeutics\u5ba3\u5e03\u4e0e\u767e\u6d4e\u795e\u5dde\u548c\u4e24\u5bb6\u673a\u6784\u6295\u8d44\u8005\u8fbe\u6210\u4e00\u98792700\u4e07\u7f8e\u5143\u7684\u80a1\u6743\u878d\u8d44\u534f\u8bae\u3002<\/p>\n<p>\u767e\u6d4e\u795e\u5dde\u514d\u75ab\u80bf\u7624\u5b66\u9996\u5e2d\u533b\u5b66\u5b98\u8d32\u52c7\u533b\u5b66\u535a\u58eb\u8868\u793a\uff1a\u201c\u6211\u4eec\u5f88\u9ad8\u5174\u80fd\u591f\u63a2\u7d22\u6297PD-1\u6297\u4f53\u66ff\u96f7\u5229\u73e0\u5355\u6297\u4e0eDKN-01\u7684\u8054\u5408\u7597\u6cd5\uff0cDKN-01\u8fc4\u4eca\u4e3a\u6b62\u5728\u751f\u7269\u6807\u5fd7\u7269\u5b9a\u4e49\u7684\u80c3\u764c\u60a3\u8005\u4e2d\u548c\u514d\u75ab\u68c0\u67e5\u70b9\u6291\u5236\u5242\u7ed3\u5408\u8868\u73b0\u79ef\u6781\u3002\u4e0eLeap Therapeutics\u7684\u5408\u4f5c\u662f\u6211\u4eec\u81f4\u529b\u4e8e\u5f00\u53d1\u521b\u65b0\u7597\u6cd5\u4ee5\u6ee1\u8db3\u4e9a\u6d32\u548c\u4e16\u754c\u5404\u5730\u5c1a\u672a\u6ee1\u8db3\u7684\u533b\u7597\u9700\u6c42\u7684\u53c8\u4e00\u4f8b\u8bc1\u3002\u201d<\/p>\n<p>\u6839\u636e\u534f\u8bae\u6761\u6b3e\uff0cLeap Therapeutics\u5c06\u4ece\u767e\u6d4e\u795e\u5dde\u83b7\u5f97300\u4e07\u7f8e\u5143\u7684\u9884\u4ed8\u73b0\u91d1\u4ed8\u6b3e\uff0c\u767e\u6d4e\u795e\u5dde\u5c06\u83b7\u5f97\u5728\u4e9a\u6d32\uff08\u65e5\u672c\u9664\u5916\uff09\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u65b0\u897f\u5170\u5f00\u53d1\u548c\u5546\u4e1a\u5316DKN-01\u7684\u72ec\u5bb6\u6388\u6743\u8bb8\u53ef\u3002<\/p>\n<p>Leap Therapeutics\u516c\u53f8\u603b\u88c1\u517c\u9996\u5e2d\u6267\u884c\u5b98Christopher K. Mirabelli\u535a\u58eb\u8868\u793a\uff1a\u201c\u5c31\u8fdb\u4e00\u6b65\u5f00\u53d1DKN-01\u5f00\u5c55\u5408\u4f5c\u4e00\u76f4\u662f\u6211\u4eec\u7684\u9996\u8981\u6218\u7565\u91cd\u70b9\u3002\u6211\u4eec\u5f88\u9ad8\u5174\u5f00\u59cb\u4e0e\u5168\u7403\u80bf\u7624\u9886\u57df\u7684\u9886\u5bfc\u8005\u767e\u6d4e\u795e\u5dde\u7684\u5408\u4f5c\uff0c\u767e\u6d4e\u795e\u5dde\u662fLeap Therapeutics\u7684\u7406\u60f3\u5408\u4f5c\u4f19\u4f34\uff0c\u4ed6\u4eec\u5728\u4e9a\u592a\u5730\u533a\u7684\u80bf\u7624\u836f\u7269\u5f00\u53d1\u65b9\u9762\u62e5\u6709\u4e30\u5bcc\u7684\u7ecf\u9a8c\uff0c\u4ed6\u4eec\u7684\u4e13\u4e1a\u77e5\u8bc6\u548c\u4e30\u5bcc\u7684\u4ea7\u54c1\u5c06\u652f\u6301\u6211\u4eec\u6ee1\u8db3\u5728\u98df\u7ba1\u80c3\u3001\u5987\u79d1\u548c\u5176\u4ed6\u764c\u75c7\u65b9\u9762\u8fdc\u672a\u88ab\u6ee1\u8db3\u7684\u533b\u7597\u9700\u6c42\u7684\u52aa\u529b\u3002\u201d<\/p>\n<p>\u5728\u9009\u62e9\u6743\u6709\u6548\u671f\u5185\uff0cLeap Therapeutics\u540c\u610f\u5c31DKN-01\u548c\u66ff\u96f7\u5229\u73e0\u5355\u6297\u8054\u5408\u7597\u6cd5\u5f00\u5c55\u7814\u7a76\u3002\u6b64\u5916\uff0cLeap Therapeutics\u8ba1\u5212\u5728\u7ea620\u4f8b\u4e00\u7ebf\u80c3\u817a\/\u80c3\u98df\u7ba1\u7ed3\u5408\u90e8\u764c\u60a3\u8005\u4e2d\u8bc4\u4f30DKN-01\u4e0e\u66ff\u96f7\u5229\u73e0\u5355\u6297\u548c\u5316\u7597\u8054\u5408\u6cbb\u7597\u7684\u7597\u6548\u3002Leap Therapeutics\u9884\u8ba1\u5c06\u57282020\u5e74\u4e0a\u534a\u5e74\u542f\u52a8\u8fd9\u4e9b\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p>\u82f1\u6587\u6765\u6e90\uff1aBiospace<\/p>\n","protected":false},"excerpt":{"rendered":"<p> Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company developing targeted immuno-oncology therapeutics, and BeiGene Co.,Ltd (Nasdaq: BGNE; HKEX: 06160)<\/p>\n","protected":false},"author":9,"featured_media":311901,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[820,455,925],"class_list":["post-311904","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-820","tag-455","tag-925","sectors-life-science-zh-hans","locations-china-zh-hans","locations-us-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/311904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=311904"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/311904\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/311901"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=311904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=311904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=311904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}